These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 27663755)

  • 1. Pro-inflammatory and anti-inflammatory T cells in giant cell arteritis.
    Watanabe R; Hosgur E; Zhang H; Wen Z; Berry G; Goronzy JJ; Weyand CM
    Joint Bone Spine; 2017 Jul; 84(4):421-426. PubMed ID: 27663755
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interferon-gamma-producing T cells in giant cell vasculitis represent a minority of tissue-infiltrating cells and are located distant from the site of pathology.
    Wagner AD; Björnsson J; Bartley GB; Goronzy JJ; Weyand CM
    Am J Pathol; 1996 Jun; 148(6):1925-33. PubMed ID: 8669478
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distinct vascular lesions in giant cell arteritis share identical T cell clonotypes.
    Weyand CM; Schönberger J; Oppitz U; Hunder NN; Hicok KC; Goronzy JJ
    J Exp Med; 1994 Mar; 179(3):951-60. PubMed ID: 8113687
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune checkpoint dysfunction in large and medium vessel vasculitis.
    Watanabe R; Zhang H; Berry G; Goronzy JJ; Weyand CM
    Am J Physiol Heart Circ Physiol; 2017 May; 312(5):H1052-H1059. PubMed ID: 28314758
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Giant cell vasculitis is a T cell-dependent disease.
    Brack A; Geisler A; Martinez-Taboada VM; Younge BR; Goronzy JJ; Weyand CM
    Mol Med; 1997 Aug; 3(8):530-43. PubMed ID: 9307981
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of JAK-STAT Signaling Suppresses Pathogenic Immune Responses in Medium and Large Vessel Vasculitis.
    Zhang H; Watanabe R; Berry GJ; Tian L; Goronzy JJ; Weyand CM
    Circulation; 2018 May; 137(18):1934-1948. PubMed ID: 29254929
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD28 Signaling Controls Metabolic Fitness of Pathogenic T Cells in Medium and Large Vessel Vasculitis.
    Zhang H; Watanabe R; Berry GJ; Nadler SG; Goronzy JJ; Weyand CM
    J Am Coll Cardiol; 2019 Apr; 73(14):1811-1823. PubMed ID: 30975299
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NADPH oxidase deficiency underlies dysfunction of aged CD8+ Tregs.
    Wen Z; Shimojima Y; Shirai T; Li Y; Ju J; Yang Z; Tian L; Goronzy JJ; Weyand CM
    J Clin Invest; 2016 May; 126(5):1953-67. PubMed ID: 27088800
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathogenesis of giant cell arteritis: new insight into the implication of CD161+ T cells.
    Samson M; Audia S; Martin L; Janikashvili N; Bonnotte B
    Clin Exp Rheumatol; 2013; 31(1 Suppl 75):S65-73. PubMed ID: 23663684
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Innate and Adaptive Immunity in Giant Cell Arteritis.
    Akiyama M; Ohtsuki S; Berry GJ; Liang DH; Goronzy JJ; Weyand CM
    Front Immunol; 2020; 11():621098. PubMed ID: 33717054
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunology of Giant Cell Arteritis.
    Weyand CM; Goronzy JJ
    Circ Res; 2023 Jan; 132(2):238-250. PubMed ID: 36656970
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The immunoinhibitory PD-1/PD-L1 pathway in inflammatory blood vessel disease.
    Weyand CM; Berry GJ; Goronzy JJ
    J Leukoc Biol; 2018 Mar; 103(3):565-575. PubMed ID: 28848042
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional profile of tissue-infiltrating and circulating CD68+ cells in giant cell arteritis. Evidence for two components of the disease.
    Wagner AD; Goronzy JJ; Weyand CM
    J Clin Invest; 1994 Sep; 94(3):1134-40. PubMed ID: 8083354
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MMP (Matrix Metalloprotease)-9-Producing Monocytes Enable T Cells to Invade the Vessel Wall and Cause Vasculitis.
    Watanabe R; Maeda T; Zhang H; Berry GJ; Zeisbrich M; Brockett R; Greenstein AE; Tian L; Goronzy JJ; Weyand CM
    Circ Res; 2018 Aug; 123(6):700-715. PubMed ID: 29970365
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Toll-like receptors 4 and 5 induce distinct types of vasculitis.
    Deng J; Ma-Krupa W; Gewirtz AT; Younge BR; Goronzy JJ; Weyand CM
    Circ Res; 2009 Feb; 104(4):488-95. PubMed ID: 19150884
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inflammatory Cell Composition and Immune-Related microRNA Signature of Temporal Artery Biopsies From Patients With Giant Cell Arteritis.
    Bolha L; Hočevar A; Suljič A; Jurčić V
    Front Immunol; 2021; 12():791099. PubMed ID: 35003111
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IL-6 expression is correlated with increased T-cell proliferation and survival in the arterial wall in giant cell arteritis.
    Manku S; Wong W; Luo Z; Seidman MA; Alabdurubalnabi Z; Rey K; Enns W; Avina-Zubieta JA; Shojania K; Choy JC
    Cardiovasc Pathol; 2018; 33():55-61. PubMed ID: 29414433
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Temporal small arterial inflammation is common in patients with giant cell arteritis.
    Zhao CL; Hui Y; Amin A
    Hum Pathol; 2018 Nov; 81():65-70. PubMed ID: 29953896
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathogenesis of Giant Cell Arteritis and Takayasu Arteritis-Similarities and Differences.
    Watanabe R; Berry GJ; Liang DH; Goronzy JJ; Weyand CM
    Curr Rheumatol Rep; 2020 Aug; 22(10):68. PubMed ID: 32845392
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deficiency of the CD155-CD96 immune checkpoint controls IL-9 production in giant cell arteritis.
    Ohtsuki S; Wang C; Watanabe R; Zhang H; Akiyama M; Bois MC; Maleszewski JJ; Warrington KJ; Berry GJ; Goronzy JJ; Weyand CM
    Cell Rep Med; 2023 Apr; 4(4):101012. PubMed ID: 37075705
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.